key: cord-0906539-pebehy9b authors: Anaya‐Saavedra, Gabriela title: Oral manifestations accompanying and related to COVID‐19: Overlooking the obvious date: 2021-04-03 journal: Oral Dis DOI: 10.1111/odi.13857 sha: 41287dbcdd1835b0276f4f7f14ce14fba8b64dd6 doc_id: 906539 cord_uid: pebehy9b nan I have followed with great interest diverse publications related to mucocutaneous manifestations occurring in individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease . From our historical findings, when a new disease emerges (such as HIV/AIDS, discovered almost four decades ago) (Septowickz, 2001) , the amount of information released is usually inversely proportional to the time required to analyse the new disease. Dermatologists were the first to publish on mucocutaneous findings of COVID-19 (Jiménez-Cauhe et al., 2020; Galván Casas et al., 2020; Recalcati, 2020) . They accurately showed that the skin findings were similar to cutaneous manifestations occurring during common viral diseases (Recalcati, 2020) , and these lesions could equally be related to drug reactions in the context of desperate therapeutic management (Jiménez-Cauhe et al., 2020; Skroza et al., 2020) . They also reported that in few cases, skin manifestations exhibited the hypercoagulative syndrome associated with severe COVID-19 (Galván- Casas et al., 2020 ). An example of such a manifestation that clearly illustrates the discussion concerning the nature of an entity, is the pseudo-chilblain. While some studies considered these entities as skin manifestations of COVID-19, an early study (Galvan-Casas et al., 2020) described their appearance as consistent with lesions commonly seen in viral exanthema. There are multiple postulated pathophysiologic mechanisms of pseudo-chilblains, including the weather and physical activity during quarantine, immune stimulation and genetic polymorphisms (Tan et al., 2021) . The controversy persists, and its association with COVID-19 is far from being confirmed (Piccolo et al., 2020; Vázquez-Osorio et al., 2021) . There is consensus on the need not to overreact if encountered and avoid alarming states that could overwhelm hospitals and care centres. have taken diverse routes. The first case series on oral manifestations (Nuno-González et al., 2020) reported various normal and common benign entities (crenate tongue, benign migratory glossitis) and inflammatory conditions (lingual papillitis, aphthous stomatitis and patchy depapillation). After rapidly clarifying the initial ambiguity (Al-Khatib, 2020; Ponce & Tjioe, 2020) , the misunderstanding persisted to what is being circulated today as a "COVID tongue," an inexistent entity that has generated doubts and fear in physicians, stomatologists and patients. Recently, a wave of letters published, introduced us to COVID-19 cases presenting discrete oral erosive lesions, traumatic ulcers and herpes simplex virus-related oral lesions. With consternation, we saw how erythematous candidiasis and benign migratory glossitis cases were published in high-impact journals, suggested as being signs of COVID-19. Our journal was not exempted, with a publication of a series of 26 cases of tongue ulcers (Riad et al., 2020) Oral manifestations in COVID-19 patients Oral mucosal lesions in patients with SARS-CoV-2 infection. Report of four cases. Are they a true sign of COVID-19 disease? Classification of the cutaneous manifestations of COVID-19: A rapid prospective nationwide consensus study in Spain with 375 cases Chikungunya fever and COVID-19: Oral ulcers are a common feature Erythema multiforme-like eruption in patients with COVID-19 infection: Clinical and histological findings Oral vesiculobullous lesions associated with SARS-CoV-2 infection Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: Oral and palmoplantar findings Can" COVID-19 tongue" be considered a pathognomonic finding in SARS-CoV-2 infection? Oral Diseases Chilblain-like lesions during the COVID-19 pandemic: Should we really worry? Overlapping findings or oral manifestations in new SARS-CoV-2 infection Cutaneous manifestations in COVID-19: A first perspective Tongue ulcers associated with SARS-CoV-2 infection: A case series Emerging and changing viral diseases in the new millennium AIDS-the first 20 years A late onset widespread skin rash in a previous Covid-19 infected patient: Viral or multidrug effect Letter to Editor: Oral lesions in a patient with Covid-19 Immunohistochemical expression of angiotensin-converting enzyme 2 (ACE2) in minor salivary glands during SARS-CoV-2 infection Skin manifestations of COVID-19: A worldwide review Oral mucositis in a SARS-CoV-2-infected patient: Secondary or truly associated condition? Oral Diseases Pseudo-chilblain lesions and COVID-19: A controversial relationship How to cite this article: Anaya-Saavedra G. Oral manifestations accompanying and related to COVID-19: Overlooking the obvious Thus, it is imperative to be precise and cautious about our knowl-